Phibro Animal Health Corporation growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +26.0%
EBITDA: +80.1%
EBIT: +93.4%
EPS: +196.7%
Free cash flow: -74.0%
Operating cash flow: -24.2%

Forward estimates

Revenue: +13.4%
EBITDA: -17.5%
EPS: +36.8%

Three-year CAGR

Revenue: +11.2%
EBITDA: +7.8%
EBIT: +11.8%
Net income: -0.6%
EPS: -0.6%
Free cash flow: -9.8%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.